News Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2024 BST			5-day change	1st Jan Change
3.78 ^USD	+18.50%		+42.64%	+11.83%

05-07	Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-17	Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference	05-08	GL
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update	05-07	GL
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update	05-07	AQ
Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting	04-17	GL
Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting	04-17	CI
Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating	03-26	MT
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	03-26	GL
Vigil Neuroscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Vigil Neuroscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-26	CI
North American Morning Briefing : Markets Steady -2-	03-26	DJ
Vigil Neuroscience Names Petra Kaufmann Chief Medical Officer	03-20	MT
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer	03-20	GL
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer	03-20	AQ
Vigil Neuroscience, Inc. Announces Executive Changes	03-20	CI
North American Morning Briefing : Stock Futures -2-	03-19	DJ
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting	03-13	GL
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting	03-13	AQ
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days	03-12	GL
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024	03-06	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Summary

Filters